Services on Demand
- Cited by Google
- Similars in SciELO
- Similars in Google
Print version ISSN 1807-5932
GIUSTI, Francesca; TONELLI, Francesco and BRANDI, Maria Luisa. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?. Clinics [online]. 2012, vol.67, suppl.1, pp.141-144. ISSN 1807-5932. http://dx.doi.org/10.6061/clinics/2012(Sup01)23.
Primary hyperparathyroidism is a common endocrinological disorder. In rare circumstances, it is associated with familial syndromes, such as multiple endocrine neoplasia type 1. This syndrome is caused by a germline mutation in the multiple endocrine neoplasia type 1 gene encoding the tumor-suppressor protein menin. Usually, primary hyperparathyroidism is the initial clinical expression in carriers of multiple endocrine neoplasia type 1 mutations, occurring in more than 90% of patients and appearing at a young age (20-25 years). Multiple endocrine neoplasia type 1/primary hyperparathyroidism is generally accompanied by multiglandular disease, clinically manifesting with hypercalcemia, although it can remain asymptomatic for a long time and consequently not always be recognized early. Surgery is the recommended treatment. The goal of this short review is to discuss the timing of surgery in patients when primary hyperparathyroidism is associated with multiple endocrine neoplasia type 1.
Keywords : Primary hyperparathyroidism; Multiple endocrine neoplasia 1; PHPT-MEN1; Subtotal parathyroidectomy; Total parathyroidectomy.